Paolo Magistri

2PUBLICATIONS
27CO-AUTHORS
Liquid biopsiesProsthetics and orthotics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 07, 2023
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma.

Lorenza Di Marco, Alessandra Pivetti, Francesco Giuseppe Foschi

|Jun 23, 2022
Low-dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation.

Christian E Oberkofler, Dimitri A Raptis, Philip C Müller

Pageof 1